Cochrane · systematic review · CD009128

Sweet potato for type 2 diabetes mellitus

Ooi, CP, Loke, SC · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library

Metabolic and Endocrine Disorders2 versionsAMSTAR 2: not assessed

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.

Questions

current version

GRADE rated

No studies

Included studies

No studies 5 · 71.4%Ungraded 0 · 0%Very low 2 · 28.6%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Ipomoea batatas (Caiapo) tablets compared to placebo for type 2 diabetes mellitus

Population: people with type 2 diabetes mellitus

CD009128.PUB3 (current) · 7 questions

Outcome	Effect	Evidence	Status / GRADE
Morbidity Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Adverse effects Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	3 studies · 140 participants	Very low Downgraded: risk of bias, imprecision
Health‐related quality of life Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Well‐being Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Functional outcomes Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Costs Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
HbA1c [%] (final values) Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	2 studies · 122 participants	Very low Downgraded: risk of bias, imprecision, indirectness

Ipomoea batatas (Caiapo) tablets compared to placebo for type 2 diabetes mellitus

Population: patients with type 2 diabetes mellitus

CD009128.PUB2 · 7 questions

Outcome	Effect	Evidence	Status / GRADE
Morbidity Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Adverse effects Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	3 studies · 140 participants	Very low Downgraded: risk of bias, imprecision
Health‐related quality of life Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Well‐being Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Functional outcomes Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
Costs Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	NR	No studies
HbA1c [%] (final values) Ipomoea batatas (Caiapo) tablets vs placebo	no estimate extracted	2 studies · 122 participants	Very low Downgraded: risk of bias, imprecision, indirectness